期刊文献+

川崎病冠状动脉损伤与纤维蛋白原Bβ-148C/T基因多态性的关系 被引量:4

Relationship between fibrinogen Bβ-148C/T polymorphism and coronary artery lesions in children with Kawasaki disease
原文传递
导出
摘要 目的探讨纤维蛋白原Bβ-148C/T基因多态性与川崎病冠状动脉损伤的关系。方法收集36例川崎病患儿与49例健康对照儿童的空腹静脉血,用辅助血浆纤维蛋白原活性测定系统测定纤维蛋白原水平和纤维蛋白原的分子功能;采用多聚酶链反应,限制性酶切方法对纤维蛋白原Bβ-148C/T位点的基因型进行测定。结果川崎病儿童冠状动脉扩张组血浆纤维蛋白原水平明显高于非扩张组及健康对照组(P<0.01);川崎病儿童冠状动脉扩张组T等位基因频率明显高于健康对照组及非扩张组(P<0.01)。结论纤维蛋白原β-148基因多态性及血浆纤维蛋白原水平与川崎病患儿冠状动脉扩张有相关性。 Objective To study the possible relationship between coronary artery lesions and fibrinogen Bβ-148 C /T polymorphism in children with Kawasaki disease.Methods Fast blood samples were taken from 36 children with Kawasaki disease(21 had coronary artery lesions) and 49 age-and gender-matched healthy children(control group).Plasma levels and molecular reactivity of fibrinogen were measured with Assist Plasma Fibrinogen Activity Assay System.Polymerize chain reaction and restriction enzyme digestion were used to detect the genotypes of fibrinogen Bβ-148C /T gene polymorphism.Results The plasma fibrinogen levels in patients with coronary artery lesions were significantly higher than those in patients without coronary artery lesions and in the control group.T allele frequency in patients with Kawasaki disease was significantly higher than that in the control group.The patients with coronary artery lesions had more increased T allele frequency compared with the patients without coronary artery lesions.Conclusions Plasma fibrinogen levels and fibrinogen Bβ-148C /T polymorphism are associated with coronary artery lesions in children with Kawasaki disease.
出处 《中国当代儿科杂志》 CAS CSCD 北大核心 2010年第7期518-520,共3页 Chinese Journal of Contemporary Pediatrics
基金 2007唐山市新药与临床医学研究计划项目(课题编号:07130206A-4-4)
关键词 纤维蛋白原 基因多态性 川崎病 儿童 Fibrinogen Gene polymorphism Kawasaki disease Child
  • 相关文献

参考文献7

二级参考文献17

  • 1杨世伟,王大为,秦玉明,李军,王凤鸣,左维嵩.川崎病患儿外周血基质金属蛋白酶-9的表达及其与冠状动脉损伤的关系(英文)[J].中国当代儿科杂志,2004,6(6):456-461. 被引量:3
  • 2符民桂,马西.中国蕲蛇毒诱导的纤维蛋白单体聚合过程的动力学分析─—纤维蛋白原转变速率的测定[J].中华血液学杂志,1994,15(4):208-209. 被引量:15
  • 3Laupland KB,Dele Davies H.Epidemiology,etiology,and management of Kawasaki disease:state of the art[J].Pediatr Cardiol,1999,20(3):177-183.
  • 4Leung DY,Meissner HC,Shulman ST.Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease[J].J Pediatr,2002,140(6):742-746.
  • 5Lin CY,Lin CC,Hwang B,Chiang BN.The changes of interleukin-2,tumour necrotic factor and gamma-interferon production among patients with Kawasaki disease[J].Eur J Pediatr,1991,150(3):179-182.
  • 6Lin CY,Lin CC,Hwang B,Chiang BN.Cytokines predict coronary aneurysm formation in Kawasaki disease patients[J].Eur J Pediatr,1993,152(4):309-312.
  • 7Okada Y,Shinohara M,Kobayashi T,Inoue Y,Tomomasa T,Kobayashi T,et al.Effect of corticosteroids in addition to intravenous gamma globulin therapy on serum cytokine levels in the acute phase of Kawasaki disease in children[J].J Pediatr,2003,143(3):363-367.
  • 8Nakamura Y, Yanagawa H, Ojimu T, et al. Cardiac sequelae of Kawasaki disease among recurrent cases [J]. Arch Dis Child, 1998, 78(2): 163-165.
  • 9Kato H, Sugimura T, Akagi T, et al. Long-term consequences of Kawasaki disease. A 10 to 20 year follow-up study of 594 patients [J]. Circulation, 1996, 94(6): 1379-1385.
  • 10Zorzi A, Colan SD, Gauvreau K, et al. Coronary artery dimensions may be misclassified as normal in Kawasaki disease [J]. J Pediatr, 1998, 133(2): 254-258.

共引文献511

同被引文献33

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部